Tìm theo
IDD-3
Thuốc Gốc
Biotech
IDD-3 is a therapeutic specific immunostimulant developed by IDM Pharma in partnership with sanofi-aventis. It consists of mature dendritic cells loaded with lysates from melanoma tumor cell lines. It includes Dendritophages that are dendritic cells, a type of specialized immune cells derived from the patient's own white blood cells.
Cơ Chế Tác Dụng : IDD-3 is a therapeutic specific immunostimulant developed by IDM Pharma in partnership with sanofi-aventis. It consists of mature dendritic cells loaded with lysates from melanoma tumor cell lines. It includes Dendritophages that are dendritic cells, a type of specialized immune cells derived from the patient's own white blood cells. IDD-3 is well tolerated with evidence of efficacy and induction of immune response in patients with progressive metastatic melanoma.
Chỉ Định : Investigated for use/treatment in melanoma.
Dữ Kiện Thương Mại
Nhà Sản Xuất
  • Công ty :
    Sản phẩm biệt dược : Uvidem
Tài Liệu Tham Khảo Thêm
drugbank
http://www.drugbank.ca/drugs/DB05427
... loading
... loading